The Result Analysis of Drug Susceptibility Test in Vitro of Mycoplasma in Urogenital Tract
Yan Zhu, Jiao Feng, Qingyang Liu
Available Online May 2017.
- https://doi.org/10.2991/ssphe-17.2017.3How to use a DOI?
- mycoplasma; ureaplasma urealyticum (Uu); mycoplasma hominis (Mh); drug susceptibility test; drug resistance; urogenital tract
- Purposes: To discuss the infected status and drug resistance of mycoplasma in urogenital. Methods: Five hundred and seventy-nine genitourinary samples were detected for the presence of mycoplasma with identification and 10 drug sensibilities by Mycoplasma Susceptibility Test Kit. Results: Two hundred and sixty-three strains (45.42%) of mycoplasma were detected from the 579 specimens. One hundred and eighty-five samples of Uu (31.95%), 15 samples of Mh (2.59%) and 63 samples of Uu and Mh (10.88%) were identified to present with positive. Because of the differences among mycoplasma types, the drug resistance of Mycoplasma to 10 antibiotics was also different. Conclusions: Josamycin (JOS) and doxycycline (DOX) were the most sensitive drug against mycoplasma infection that, they were the first choice. Furthermore, both roxithromycin and azithromycin showed the resistance to mycoplasma infection, so they couldn't be used for treating the infection. There were some differences between drug sensitivity and drug resistance. With respect to drug susceptibility test, antimicrobial agents should be selected so as to reduce the resistant strains and give patients standard treatment.
- Open Access
- This is an open access article distributed under the CC BY-NC license.
Cite this article
TY - CONF AU - Yan Zhu AU - Jiao Feng AU - Qingyang Liu PY - 2017/05 DA - 2017/05 TI - The Result Analysis of Drug Susceptibility Test in Vitro of Mycoplasma in Urogenital Tract BT - Proceedings of the International Conference on Social Science, Public Health and Education (SSPHE 2017) PB - Atlantis Press SP - 11 EP - 16 SN - 2352-5398 UR - https://doi.org/10.2991/ssphe-17.2017.3 DO - https://doi.org/10.2991/ssphe-17.2017.3 ID - Zhu2017/05 ER -